Al­ny­lam seeks com­pen­sa­tion from Mod­er­na and Pfiz­er in suits over patent­ed de­liv­ery of their Covid-19 vac­cines

RNAi ther­a­peu­tics jug­ger­naut Al­ny­lam Phar­ma­ceu­ti­cals on Thurs­day an­nounced that it’s su­ing and seek­ing mon­ey from both Pfiz­er and Mod­er­na re­gard­ing their use of Al­ny­lam’s biodegrad­able …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER